145 related articles for article (PubMed ID: 15572361)
1. IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
Kim EJ; Park JI; Nelkin BD
J Biol Chem; 2005 Feb; 280(6):4913-20. PubMed ID: 15572361
[TBL] [Abstract][Full Text] [Related]
2. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
Park JI; Strock CJ; Ball DW; Nelkin BD
Mol Cell Biol; 2003 Jan; 23(2):543-54. PubMed ID: 12509453
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
Park JI; Strock CJ; Ball DW; Nelkin BD
Cytokine; 2005 Feb; 29(3):125-34. PubMed ID: 15613280
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
Arthan D; Hong SK; Park JI
Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
[TBL] [Abstract][Full Text] [Related]
5. Recombinant leukemia inhibitory factor suppresses human medullary thyroid carcinoma cell line xenografts in mice.
Starenki D; Singh NK; Jensen DR; Peterson FC; Park JI
Cancer Lett; 2013 Oct; 339(1):144-51. PubMed ID: 23856028
[TBL] [Abstract][Full Text] [Related]
6. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998
[TBL] [Abstract][Full Text] [Related]
7. Alternative signaling mechanism of leukemia inhibitory factor responsiveness in a differentiating embryonal carcinoma cell.
Takeda T; Kurachi H; Yamamoto T; Homma H; Adachi K; Morishige K; Miyake A; Murata Y
Endocrinology; 1997 Jul; 138(7):2689-96. PubMed ID: 9202205
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of the effect of forced activation of STAT3 on M1 mouse leukemia cells.
Yoshida T; Iwamoto T; Adachi K; Yokota T; Miyake Y; Hamaguchi M
Int J Mol Med; 2005 Feb; 15(2):269-75. PubMed ID: 15647843
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
10. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
[TBL] [Abstract][Full Text] [Related]
11. Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells.
Tanuma N; Nakamura K; Shima H; Kikuchi K
J Biol Chem; 2000 Sep; 275(36):28216-21. PubMed ID: 10859312
[TBL] [Abstract][Full Text] [Related]
12. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
Quentmeier H; Zaborski M; Drexler HG
Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
[TBL] [Abstract][Full Text] [Related]
13. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
Piekorz RP; Hocke GM
Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
[TBL] [Abstract][Full Text] [Related]
14. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.
Kunisada K; Hirota H; Fujio Y; Matsui H; Tani Y; Yamauchi-Takihara K; Kishimoto T
Circulation; 1996 Nov; 94(10):2626-32. PubMed ID: 8921810
[TBL] [Abstract][Full Text] [Related]
15. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells.
Boeuf H; Hauss C; Graeve FD; Baran N; Kedinger C
J Cell Biol; 1997 Sep; 138(6):1207-17. PubMed ID: 9298977
[TBL] [Abstract][Full Text] [Related]
16. Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor.
Laszlo GS; Nathanson NM
J Biol Chem; 2003 Jul; 278(30):27750-7. PubMed ID: 12764151
[TBL] [Abstract][Full Text] [Related]
17. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
[TBL] [Abstract][Full Text] [Related]
19. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor as a mediator of JAK/STAT activation in murine osteoblasts.
Lowe C; Gillespie GA; Pike JW
J Bone Miner Res; 1995 Nov; 10(11):1644-50. PubMed ID: 8592940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]